Evotec SE EVO
NASDAQ EVO
$1.67 +0.05 (+3.09%)
At close: Sep 17, 2026 · 4:00 PM EDT

Evotec SE (EVO) Net Equity Issued and Repurchased (2010)

Evotec SE's (EVO) quarterly Net Equity Issued and Repurchased came in at $15.23 in Q1 2010.

Analysis

Evotec SE (EVO) Net Equity Issued and Repurchased (2010) Analysis & Trends

Evotec SE has disclosed Net Equity Issued and Repurchased across 1 years of filings, most recently posting $15.23 for Q1 2010.

  • In Q1 2010, Net Equity Issued and Repurchased changed N/A year-over-year to $15.23; the TTM figure through Dec 2022 stood at -$1432.8 (changed N/A YoY), while the FY2022 annual figure was $374154.4, down 99.92% from the prior year.
  • Net Equity Issued and Repurchased came in at $15.23 for Q1 2010 at Evotec SE.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $15.23 in Q1 2010 to a low of $15.23 in Q1 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2010 15.23